114 related articles for article (PubMed ID: 2412503)
1. Influence of ingested load on postprandial insulin secretion. Rôle of gastric inhibitory polypeptide (GIP).
Beck B; Villaume C
Arch Int Physiol Biochim; 1985 Jun; 93(2):101-6. PubMed ID: 2412503
[TBL] [Abstract][Full Text] [Related]
2. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
[TBL] [Abstract][Full Text] [Related]
4. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
Ebert R; Arnold R; Creutzfeldt W
Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
[TBL] [Abstract][Full Text] [Related]
5. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
6. Influence of caloric intake on gastric inhibitory polypeptide, VIP and gastrin release in man.
Beck B; Villaume C; Chayvialle JA; Gariot P; Ulmer M; Desalme A; Debry G
Peptides; 1984; 5(2):403-6. PubMed ID: 6473163
[TBL] [Abstract][Full Text] [Related]
7. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
Ebert R; Creutzfeldt W
Acta Diabetol Lat; 1989; 26(1):1-15. PubMed ID: 2665406
[TBL] [Abstract][Full Text] [Related]
8. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
Mazzaferri EL; Starich GH; St Jeor ST
J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
[TBL] [Abstract][Full Text] [Related]
9. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
Ebert R; Creutzfeldt W
Diabetologia; 1980 Sep; 19(3):198-204. PubMed ID: 6997121
[TBL] [Abstract][Full Text] [Related]
10. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
11. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
12. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
13. Circadian rhythm of gastric inhibitory polypeptide (GIP) in man.
Salera M; Giacomoni P; Pironi L; Ustra C; Capelli M; Giorgi A; Miglioli M; Barbara L
Metabolism; 1983 Jan; 32(1):21-4. PubMed ID: 6336815
[TBL] [Abstract][Full Text] [Related]
14. The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man.
Jorde R; Burhol PG; Schulz TB; Waldum HL; Lygren I; Jenssen T; Myhre ES
Scand J Gastroenterol; 1981; 16(1):109-12. PubMed ID: 7015476
[TBL] [Abstract][Full Text] [Related]
15. Glucose-dependent insulin-releasing peptide in noninsulin-dependent maturity-onset diabetes: effects of autonomic neuropathy.
Levitt NS; Vinik AI; Child PT
J Clin Endocrinol Metab; 1980 Aug; 51(2):254-8. PubMed ID: 6995476
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide and insulin-like immunoreactivity in saliva following sham-fed and swallowed meals.
Messenger B; Clifford MN; Morgan LM
J Endocrinol; 2003 Jun; 177(3):407-12. PubMed ID: 12773121
[TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
[TBL] [Abstract][Full Text] [Related]
18. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
19. [Effect of different dietary loads on glucose-dependent insulinotropic polypeptide in subjects with normal glucose tolerance].
Chen Z; Yan L; Fu XY; Yang HZ; Kuang J
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2031-4. PubMed ID: 22200706
[TBL] [Abstract][Full Text] [Related]
20. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]